Evaluation of a Low-threshold Exercise And Protein supplementation intervention for Women (LEAP-W) experiencing homelessness and addiction: Protocol for a single site intervention study ========================================================================================================================================================================================= * Fiona Kennedy * Deirdre Murray * Clíona Ní Cheallaigh * Roman Romero-Ortuno * Julie Broderick ## Abstract **Background** Frailty is a complex multi-dimensional state of increased vulnerability to adverse health outcomes and is usually associated with older age but there is growing evidence of accelerated ageing and frailty in non-geriatric populations, including those experiencing socio-economic deprivation and extreme social exclusion, such as people experiencing homelessness. Addiction, as a coping mechanism for prior trauma, is common among people who are homeless and can have a gendered dimension. Women experiencing homelessness and addiction have unique needs which require a gendered approach. The aim of this study is to explore the effectiveness of an exercise intervention to target the known physical functioning deficits and frailty which this population experiences. **Methods** This mixed-methods study will explore physical functioning deficits and frailty in women experiencing homelessness and addiction, using a bespoke test battery and an exercise intervention. Physical function (10m Walk Test, 2 Min Walk Test, Single Leg Stance, Chair Stand Test, hand grip dynamometry), frailty (Clinical Frailty Scale and the SHARE- Frailty Instrument) and nutritional status (Mini-Nutritional Status), pain (Numerical Pain Rating Scale) and quality of life (SF 12-V2) will be evaluated. The 10-week intervention will involve a 3-times weekly exercise programme with protein supplementation. Following this, qualitative interviews, which will be thematically analysed using Braun & Clarke methodology, will be conducted. This study will be conducted in Dublin from February to July 2024. **Discussion** Little is known about frailty-focussed interventions in women experiencing homelessness and addiction. This proposed study will help to increase the knowledge base regarding the physical health burden and frailty experienced by this extremely vulnerable population and will deliver a targeted intervention with a gendered dimension to mitigate its affects. The findings of this research will help narrow this research gap and will guide clinicians and policy makers to implement unique gender-based treatment strategies for this population. (299 words) Keywords * Physical function * frailty * homelessness * addiction * women ## Introduction The world’s population is ageing rapidly (1). Frailty, a sometimes-preventable consequence of a rapidly ageing population, is a complex state of cumulative decline across multiple physiological systems which renders a person vulnerable to adverse health outcomes and greatly challenges healthcare systems (2). Targeted interventions to manage frailty in older adults are recommended and exercise with nutritional supplementation has proven effectiveness in combatting and mitigating frailty (3, 4, 5). Frailty as a construct is a geriatric concept which is strongly associated with increasing age (6). Notwithstanding that biological age is closely linked to frailty, it is known that chronological age alone will not identify frailty as the health and functional life status of populations are so variable (7). Growing evidence indicates the prevalence of premature ageing and frailty in non-geriatric populations (8, 9). ‘Younger frailty’ has been identified in populations of lower socioeconomic status, who live in areas of greater deprivation and experience an earlier onset of illness and disability (10, 11). In a study investigating people experiencing homelessness (PEH) admitted for inpatient care, 83% of participants had mobility problems and 70% were frail or pre-frail despite a low median age of 45 years (12, 13). In an analysis of UK Biobank participants aged 37–73 years, 42% of individuals living with frailty were within the most socially deprived 20% of the cohort (10). Females are known to experience higher levels of frailty compared to males (14, 15). It is therefore not surprising that poor physical functioning and frailty is experienced by young women who are homeless and use drugs (16, 17). Health services for PEH frequently focus on crisis-based medical, nursing and addiction services, often with a gender-blind lens (18, 19). High levels of stigma, shame and fear result in women accessing services even less and seeking help at breaking point with complex coinciding physical and mental health needs (20, 21). Homelessness and substance use in women is inter-sectoral and may overlap with trauma, abuse, domestic and sexual violence and exploitation, and the needs of these women are complex and unique (22). Pathways into homelessness are frequently different to that of men and require a different approach (23). Internationally, gender-based services for women who are experiencing homelessness and addiction are lacking and services are mostly delivered in mixed gender settings (18, 20). Women-specific services are recommended to increase safety, stability, wellbeing, and psychosocial functioning to respond meaningfully to the serious health and social care needs of women in this setting (24). Gender specific and gender sensitive research is required to fill this knowledge gap (25). Our prior research, the LEAP I study demonstrated high retention (83% female v 42% males) with excellent engagement and feedback from its female participants, yet caution was observed around engaging in a mixed exercised programme with men (26). Women have traditionally been underserved in research and policy, yet multiple sources cite women as the fastest growing homeless demographic (23). No study has examined how targeted women-only exercise programmes with nutritional supplementation work in practice in this population. The overall aim of this study is to explore physical functioning and frailty outcomes of an exercise intervention with protein supplementation in a group of (non-geriatric) women experiencing homelessness and addiction challenges. The objectives are: 1. To evaluate recruitment, retention and adherence rates, and any adverse effects of the intervention. 2. To evaluate pre- and post-intervention levels of physical function, nutritional and frailty status, pain, and general health status. 3. To evaluate programme feedback and gain deeper insights into participants perspectives and experiences of the exercise intervention. ## Materials and Methods ### Study design, setting and time frame This mixed-methods study will involve a single-arm intervention which will take place in Jane’s Place, Merchants Quay Ireland (MQI), in Dublin city centre, a day- service centre which provides services for women who are homeless and/or in addiction. Following the intervention qualitative research in the form of individual exit interviews will be conducted with 20 participants or up to the point of data saturation. This study has received ethical approval from the Faculty of Health Sciences, Trinity College Dublin (Ethical Approval Reference Number: 211202). ### Study population, eligibility criteria and recruitment strategy #### Study population This study will involve a non-geriatric population of women who attend Jane’s Place in Dublin city centre. These women have complex needs, many experiencing homelessness and addiction challenges. #### Eligibility criteria Inclusion criteria: * ➢ Adult women (18-65 years) accessing services in Jane’s Place who consent to participation. Exclusion criteria: * ➢ Any person not meeting the age eligibility criteria. * ➢ Any person identifying as a male. * ➢ Any person lacking capacity to give consent. * ➢ Any person with major physical/medical or cognitive challenges which would preclude ability to safely complete the assessment or * ➢ Any person with insufficient English language ability to give fully informed consent. * ➢ Women with a confirmed pregnancy. #### Recruitment Strategy All potential participants will be provided with a participant information leaflet (PIL) detailing the purpose of the data collection, potential risks and benefits and data protection rights. Where possible a seven-day gap, between receipt of the PIL and obtaining consent, will be provided to allow people time to consider participation. However, if it is their preference to be seen at an earlier and more convenient time this will be facilitated due to the innocuous nature of the evaluation. Once the research physiotherapist is satisfied that the participant has read and fully understands the PIL, they will proceed to obtain written informed consent. Obtaining consent will take place at the first face to face interaction with the participant prior to commencement of the assessment. The written consent informs participants that they are permitted to withdraw from the study at any time. They will be provided with their own copy of this consent form and PIL with their own signature and that of the research physiotherapist. #### Stakeholder engagement Recommendations from the linked LEAP II trial (16) included health education and awareness workshops preceding exercise interventions to enhance health literacy, target lifestyle behavioural change and improve retention rates. Prior to the LEAP- W programme, a number of exercise workshops will be delivered for staff and service users in Jane’s Place. Feedback from this stakeholder engagement will inform the design of the intervention. ### Evaluation and test battery Using a bespoke data collection form, the following demographic data will be collected: age, gender, ethnicity, living arrangement and environment, highest level of education, marital status, employment status, history of incarceration, history of addiction, self- reported health, and medical history. Physical function, frailty and other related variables will be evaluated using the test battery outlined in Table 1. View this table: [Table 1.](http://medrxiv.org/content/early/2024/03/02/2024.02.29.24303542/T1) Table 1. Test Battery. #### 1. Strength and muscular mass Muscle strength will be measured, using a Jamar Digital Hand Dynamometer, while sitting with the elbow flexed at 90°, the forearm mid-prone, the wrist in neutral and the hand unsupported (27, 28). Results will be compared to normative reference values (38). Two measurements will be recorded and also used for the SHARE-Frailty Instrument (FI) assessment (33). Mid-calf circumference girth will be evaluated as this measure correlates with appendicular muscular mass (39). This will be measured using a flexible tape measure at the level of the largest circumference of the calf. Measurements will be compared to gendered cut-off values (40). Mid-arm muscle circumference reflects both muscle mass and caloric and protein adequacy and may be used to signify wasting or malnutrition (41). This test has been recommended in situations where lower limb swelling is present (42). The maximum upper arm muscular mass will be measured using a flexible tape measure. Results will be compared to global reference values (43). #### 2. Physical performance and lower extremity physical function This will be measured using the following physical performance measures: * (i) The 10m Walk Test (10mWT). This test measures gait speed and functional mobility and is recorded in m/s. Gait speed is calculated as total distance/time (31). * (ii) The 2 Minute Walk Test (2MWT). This test of self-paced walking ability and functional capacity assesses a participants’ ability to walk unaided over a 15m distance, as fast as possible, for two minutes. Rest breaks are permitted, and the distance covered is measured (30). * (iii) The Chair Stand Test (CST). This tests lower limb strength and endurance and records the total number of sit to stand repetitions performed in 30 seconds (29). * (iv) The Single Leg Stance Test (SLST). This balance test is performed on each leg. The participant is timed standing unassisted on one leg, with eyes open and hands placed on the hips (32). #### 3. Pain Each participant will be asked if they are experiencing pain and will be questioned about its location and duration. Pain severity will be assessed using the Numerical Rating Scale (NRS) (34). The NRS is a unidimensional measure of pain intensity from 0-10, with 0 being zero pain and 10 the worst pain imaginable. #### 4. Frailty Frailty will be assessed using the Clinical Frailty Scale (CFS) (6) and the SHARE- Frailty Instrument (FI) (33). The CFS is validated for people over 65 years. It is assessed by the tester. Each point on the scale correlates with a level of frailty and a visual chart aids classification from 1 (very fit) to 9 (terminally ill). Higher scores indicate higher levels of frailty. The SHARE-FI is validated for people over 50 years (33). It consists of four brief questions related to the following variables: exhaustion, loss of appetite, walking difficulties and low physical activity, and grip strength measurement. The five results are entered into a freely available web calculator to generate a frailty score and a frailty category of non-frail, pre-frail and frail is also generated. A minor modification was made to the terminology of the SHARE-FI to reflect the real-world experiences of this population. #### 5. Nutritional status will be assessed using the Mini-nutritional assessment (MNA) which assesses the risk of malnutrition (36). The short form of the MNA (MNA-SF) (37) is an efficient screening tool consisting of six questions on food intake, weight loss, mobility, psychological stress, or acute disease, the presence of dementia or depression, and body mass index (BMI). The maximum score for this part is equal to 14. A score of 12 or higher indicates a normal nutritional status thus excluding malnutrition and/or malnutrition risk. A score of 11 of less indicates the requirement to proceed with the complete version of the MNA (MNA-LF) (37). The terminology of two of the questions of the MNA (regarding acuity of illness and psychological stress) were slightly modified for the purposes of evaluation of this population in this setting. #### 8. Short-Form 12 (SF-12) The SF-12 V2 is a self-report measure of health used across age, disease, and treatment groups (35). It uses eight domains including physical and social activities, pain, mental health, emotional health, vitality and general health perceptions to measure health. The tester will read and complete the 12-question survey with the participant. Results will be entered into a software program provided by the licensing company QualityMetric and two summary scores, mental health (MCS12) and physical health (PCS12) will be generated. The assessor will document any issues with terminology of the outcome measures utilised, difficulties with completion or floor or ceiling effects reached, as these instruments were designed with geriatric populations in mind. ##### Intervention This intervention study will be conducted for 10 weeks. It will involve a low threshold, three-times weekly exercise intervention (two exercise classes with protein supplementation and an outdoor ‘Park Walk’). The intervention will be delivered by two research physiotherapists who will adhere to all safety procedures. Flexibility will be facilitated with the provision of a four-week window for pre-intervention evaluations prior to commencement of the programme. Using a trauma-informed lens (20) flexibly arranged group or one-to one sessions will be delivered based on participant preference. Exercise programming strategies and variables are based on our earlier work (LEAP I and LEAP II trials) (16, 17) and also informed by prior stakeholder involvement from people with lived experience. The exercise classes will be multi-modal, with a primary focus on strength and based on core set of resistance exercises (Table 2). Aerobic, balance and flexibility work will be integrated into the class and the exercises will be individualised based on initial assessment results and presentation of participants. Using a gender- based perspective, the following considerations and adaptions will be built into the class; (i) core-stability exercises to target pelvic floor and/or abdominal muscle weakness, (ii) bone building exercises to target peri-and postmenopausal bone loss and (iii) age- associated muscle mass loss. Music, dance and fun orientated physical activity games, an important feature of aforementioned linked studies, will be incorporated to optimize enjoyment and self-esteem. Borg’s Rate of Perceived Exertion Scale will be used to monitor effort and scale the intensity of the workout (44). To promote post-exercise muscle protein synthesis, a nutritional supplement (200ml pre-prepared ‘protein shake’, Fresubin) which consists of 20g of protein will be offered immediately post exercise. The ‘Park Walk’ will focus on the aerobic component of the intervention, using open green space to maximise physical and mental health outcomes. It will be a flexibly arranged 20–30-minute self-paced group or one-to-one walk. To build sustainability beyond the ten-week programme brief health promoting and physical activity educational interventions will be included in the exercise class setting to empower people to engage in unsupervised exercise following the study. View this table: [Table 2.](http://medrxiv.org/content/early/2024/03/02/2024.02.29.24303542/T2) Table 2. Exercise Circuit. ##### Qualitative data Following the intervention one-to-one in-person exit interviews will be conducted to enable participants to share their feedback and express their views, in order to enhance the understanding of behaviours, adherence and retention challenges and to provide insights for future programmes in this area (45) (S3 Fig). Interviews will continue until 20 participants are seen or until data saturation is reached. The interviews will be audio- recorded and transcribed verbatim and member checking will be utilised. ##### Sample size As this is a novel field of research, sample size calculations are challenging. The sample method used will be non-probability, convenience sampling, involving the recruitment of a tailored sample that is in proportion to characteristics of the population of interest. This approach may limit generalisability of results but will minimise selection bias (46). A sample size of 30 or greater has been proposed for feasibility studies (47). Considering this and the aim and objectives of this study a target of 40-50 participants has been selected, to allow for drop-out rate of approximately 30%. ## Data collection and management ### Analytic plan All data will be pseudonymised at point of entry into excel spreadsheets and then transferred into IBM SPSS V28 for analysis. For quantitative data, nominal or ordinal variables will be reported as frequencies and percentages. Continuous variables will be summarised as mean and standard deviation if normally distributed and median and inter- quartile range if non-normally distributed. Data will be tested for normality using the Kolmogorov–Smirnov/Shapiro Wilk test and will be compared across timepoints using the general linear model procedure (normally distributed data) and the Friedman’s test (non- normally distributed data). Chi-squared t-tests will be used where appropriate and some data may be categorised to investigate relationships between variables. Exploratory regression models will be developed to explore correlates and predictors of frailty and poor physical functioning. A *p*-value of <0.05 will be considered significant. For the qualitative data, Braun and Clarke thematic analysis methodology will be employed to provide an in- depth analysis of the exit interview data (48). ## Discussion Poor physical functioning and frailty has been demonstrated in younger populations who suffer from health disparities and an extreme form of social exclusion, such as PEH and addiction challenges (12, 13, 49). Women who experience homelessness and addiction are especially vulnerable and have unique and complex needs which require a targeted and gender-sensitive approach. Little is known about frailty-focussed interventions in this population, who are often excluded from research and services (18). However, this population have engaged well in two previous linked studies (LEAP I and II). This study aims to address the research gap by providing a targeted exercise intervention to women experiencing homelessness and addiction challenges, thereby providing a gendered dimension, with gendered sensitivity. Its findings will guide clinicians and policy makers in implementing targeted interventions to assist in improving health outcomes in societies most marginalised and vulnerable groups. ## Study status Recruitment and data collection will commence in February 2024 and will be completed by July 2024. ## Funding This has been funded by Trinity College Dublin and the Irish Research Council. ## Dissemination plans Conference presentations and publications in peer-reviewed journals will be one method of dissemination. These will be done following the data analysis. ## Competing interests The authors have no competing interests to declare in connection with this article. ## Data availability There are no underlying data associated with this protocol. Data from this study will be available in open access form. ## Supporting information S1 Fig. Exit Interview Schedule ## Acknowledgments The authors wish to extend their gratitude to the staff of Jane’s Place, MQI who are helping to recruit participants. ## Footnotes * FK and JB are Joint Senior Authors * & R.RO, CNC and DM contributed equally to this work. * Clinical Trials.gov number: *NCT05700305* * Received February 29, 2024. * Revision received February 29, 2024. * Accepted March 2, 2024. * © 2024, Posted by Cold Spring Harbor Laboratory This pre-print is available under a Creative Commons License (Attribution 4.0 International), CC BY 4.0, as described at [http://creativecommons.org/licenses/by/4.0/](http://creativecommons.org/licenses/by/4.0/) ## References 1. 1.Nations U. Global Issues: Our growing population2023. Available from: [https://www.un.org/en/global-issues/population](https://www.un.org/en/global-issues/population). 2. 2.Morley JE, Vellas B, van Kan GA, Anker SD, Bauer JM, Bernabei R et al. Frailty consensus: a call to action. J Am Med Dir Assoc, 2013. (6): p. 392–7. doi: 10.1016/j.jamda.2013.03.022. [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1016/j.jamda.2013.03.022&link_type=DOI) 3. 3.Turner G and Clegg A. Best practice guidelines for the management of frailty: a British Geriatrics Society, Age UK and Royal College of General Practitioners report. Age Ageing. 2014;43(6):744–7. doi: 10.1093/ageing/afu138. [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1093/ageing/afu138&link_type=DOI) [PubMed](http://medrxiv.org/lookup/external-ref?access_num=25336440&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2024%2F03%2F02%2F2024.02.29.24303542.atom) 4. 4.Travers J, Romero-Ortuno R, Bailey J & Cooney MT. Delaying and reversing frailty: a systematic review of primary care interventions. Br J Gen Pract, 2019. 69(678): p. e61–e69. doi: 10.3399/bjgp18X700241. [Abstract/FREE Full Text](http://medrxiv.org/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6NDoiYmpncCI7czo1OiJyZXNpZCI7czoxMDoiNjkvNjc4L2U2MSI7czo0OiJhdG9tIjtzOjUwOiIvbWVkcnhpdi9lYXJseS8yMDI0LzAzLzAyLzIwMjQuMDIuMjkuMjQzMDM1NDIuYXRvbSI7fXM6ODoiZnJhZ21lbnQiO3M6MDoiIjt9) 5. 5.Travers J, Romero-Ortuno R, Langan J, MacNamara F, McCormack D, McDermott C, et al. Building resilience and reversing frailty: a randomised controlled trial of a primary care intervention for older adults. Age Ageing, 2023. 52(2). doi: 10.1093. [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1093&link_type=DOI) 6. 6.Rockwood K, Song X, MacKnight C, Bergman H, Hogan DB, McDowell I et al. A global clinical measure of fitness and frailty in elderly people. Cmaj, 2005. 173(5): p. 489–95. doi: 10.1503/cmaj.050051. [Abstract/FREE Full Text](http://medrxiv.org/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6NDoiY21haiI7czo1OiJyZXNpZCI7czo5OiIxNzMvNS80ODkiO3M6NDoiYXRvbSI7czo1MDoiL21lZHJ4aXYvZWFybHkvMjAyNC8wMy8wMi8yMDI0LjAyLjI5LjI0MzAzNTQyLmF0b20iO31zOjg6ImZyYWdtZW50IjtzOjA6IiI7fQ==) 7. 7.Romero-Ortuno R and O’Shea D. Fitness and Frailty: opposite ends of a challenging continuum! Will the end of age discrimination make frailty assessments an imperative? Ae Ageing, 2013. 42(3) p. 279–80. doi:10.1093/ageing/afs189. [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1093/ageing/afs189&link_type=DOI) [PubMed](http://medrxiv.org/lookup/external-ref?access_num=23348509&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2024%2F03%2F02%2F2024.02.29.24303542.atom) 8. 8.Loecker C, Schmaderer M, Zimmerman L. Frailty in Young and Middle-Aged Adults: An Integrative Review. J Frailty Aging. 2021;10(4):327–33. doi: 10.14283/jfa.2021.14. [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.14283/jfa.2021.14&link_type=DOI) 9. 9.Spiers GF, Kunonga TP, Hall A, Beyer F, Boulton E, Parker S, et al. Measuring frailty in younger populations: a rapid review of evidence. BMJ Open. 2021;11(3):e047051. doi: 10.1136/bmjopen-2020-047051. [Abstract/FREE Full Text](http://medrxiv.org/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6NzoiYm1qb3BlbiI7czo1OiJyZXNpZCI7czoxMjoiMTEvMy9lMDQ3MDUxIjtzOjQ6ImF0b20iO3M6NTA6Ii9tZWRyeGl2L2Vhcmx5LzIwMjQvMDMvMDIvMjAyNC4wMi4yOS4yNDMwMzU0Mi5hdG9tIjt9czo4OiJmcmFnbWVudCI7czowOiIiO30=) 10. 10.Hanlon P, Nicholl BI, Jani BD, Lee D, McQueenie R, Mair FS. Frailty and pre-frailty in middle-aged and older adults and its association with multimorbidity and mortality: a prospective analysis of 493 737 UK Biobank participants. Lancet Public Health. 2018;3(7):e323–e32. doi: 10.1016/S2468-2667(18)30091-4 [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1016/S2468-2667(18)30091-4&link_type=DOI) 11. 11.Aldridge RW, Story A, Hwang SW, Nordentoft M, Luchenski SA, Hartwell G, et al. Morbidity and mortality in homeless individuals, prisoners, sex workers, and individuals with substance use disorders in high-income countries: a systematic review and meta-analysis. Lancet. 2018;391(10117):241–50. doi: 10.1016/S0140-6736(17)31869-X. [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1016/S0140-6736(17)31869-X&link_type=DOI) [PubMed](http://medrxiv.org/lookup/external-ref?access_num=29137869&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2024%2F03%2F02%2F2024.02.29.24303542.atom) 12. 12.Broderick J, Kiernan S, Murphy N, Dowds J, C NC. Feasibility of a Broad Test Battery to Assess Physical Functioning Limitations of People Experiencing Homelessness. Int J Environ Res Public Health. 2021;18(3). doi: 10.3390/ijerph18031035. [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.3390/ijerph18031035&link_type=DOI) 13. 13.Kiernan S, C NC, Murphy N, Dowds J, Broderick J. Markedly poor physical functioning status of people experiencing homelessness admitted to an acute hospital setting. Sci Rep. 2021;11(1):9911. doi: 10.1038/s41598-021-88590-0. [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1038/s41598-021-88590-0&link_type=DOI) [PubMed](http://medrxiv.org/lookup/external-ref?access_num=http://www.n&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2024%2F03%2F02%2F2024.02.29.24303542.atom) 14. 14.Tembo MC, Holloway-Kew KL, Sui SX, Dunning T, Low ACH, Yong SJ, et al. Prevalence of Frailty in Older Men and Women: Cross-Sectional Data from the Geelong Osteoporosis Study. Calcif Tissue Int. 2020;107(3):220–9. doi: 10.1007/s00223-020-00713-3. [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1007/s00223-020-00713-3&link_type=DOI) 15. 15.Zhang Q, Guo H, Gu H, Zhao X. Gender-associated factors for frailty and their impact on hospitalization and mortality among community-dwelling older adults: a cross-sectional population- based study. PeerJ. 2018;6:e4326. doi: 10.7717/peerj.4326. [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.7717/peerj.4326&link_type=DOI) 16. 16.Kennedy F, Romero-Ortuno R, Ní Cheallaigh C, Doyle S and Broderick, J. "It’s like a free drug"-Low Threshold Exercise and Nutritional Programmes for People with Severe and Multiple Disadvantage Accessing Services for Addicition Chaleenges and Homelessness. Pathways from Homelessness. International Conference of the Faculty for Homeless and Inclusion Helath; 2023 March 16-17, 2023; London. 17. 17.Kennedy, F., Ní Cheallaigh, C., Romero-Ortuno, R., Doyle, S. and Broderick, J. Outcomes of the LEAP feasibility trial-a low threshold exercise programme with protein supplementation to target frailty and poor physical functioing in people experiencing homelessness and addiction issues. PLOS ONE *(in press)* 18. 18.Addiction EMCfDaD. Health and Social responses to drug problems: A European Guide2022. Available from: [https://www.emcdda.europa.eu/publications/mini-guides/homelessness-and-drugs-health-and-social-responses\_en](https://www.emcdda.europa.eu/publications/mini-guides/homelessness-and-drugs-health-and-social-responses_en). 19. 19. C NC, Cullivan S, Sears J, Lawlee AM, Browne J, Kieran J, et al. Usage of unscheduled hospital care by homeless individuals in Dublin, Ireland: a cross-sectional study. BMJ Open. 2017;7(11):e016420. doi: 10.1136/bmjopen-2017-016420. [Abstract/FREE Full Text](http://medrxiv.org/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6NzoiYm1qb3BlbiI7czo1OiJyZXNpZCI7czoxMjoiNy8xMS9lMDE2NDIwIjtzOjQ6ImF0b20iO3M6NTA6Ii9tZWRyeGl2L2Vhcmx5LzIwMjQvMDMvMDIvMjAyNC4wMi4yOS4yNDMwMzU0Mi5hdG9tIjt9czo4OiJmcmFnbWVudCI7czowOiIiO30=) 20. 20. FEANTSA EFoNOWwtHFEWaH. 2019-2021. Available from: [https://www.feantsa.org/en/project/2019/01/03/women-and-homelessness](https://www.feantsa.org/en/project/2019/01/03/women-and-homelessness). 21. 21.The Department of Housing, Planning and Local Government (Feb 2018) Homelessness Report. 2018. Available from: [https://www.gov.ie/en/publication/793bc-homeless-report-february-2018/?referrer=](https://www.gov.ie/en/publication/793bc-homeless-report-february-2018/?referrer=)[http://www.housing.gov.ie/sites/default/files/publications/files/homelessness\_report\_-\_february\_2018\_0.pdf](http://www.housing.gov.ie/sites/default/files/publications/files/homelessness\_report\_-_february_2018_0.pdf) 22. 22.Mutatayi C MS, Robles Soto N, Palsdottor K & Vale Pires C. Implementing a Gender Approach in Drug Policies: Prevention, Treatment and Criminal Justice. A handbook for practitioners and decision makers. Council of Europe:Strasbourg.2022. Available from: [https://www.drugsandalcohol.ie/36974/](https://www.drugsandalcohol.ie/36974/) 23. 23.Milani K, Ramage, K., Yang Fang, X. and Louis, M. Understanding Mothers experiencing homelessness: A gendered approach to finding solutions for family homelessness. 2016. Available from: [https://www.homelesshub.ca/sites/default/files/attachments/Family\_Homelessness\_Report.pdf](https://www.homelesshub.ca/sites/default/files/attachments/Family_Homelessness_Report.pdf) 24. 24.Morton SG, B. and McLoughlin, E. . "You can’t fix this in six months": The intersectionality of women’s substance use in the Irish context. . In: Ireland UCDaMQ, editor. 2023 Available from: [https://www.drugsandalcohol.ie/38492/](https://www.drugsandalcohol.ie/38492/) 25. 25.European Commission, Directorate-General for Research and Innovation, Gender in EU-funded research – Toolkit, Publications Office, 2014, [https://data.europa.eu/doi/10.2777/74150](https://data.europa.eu/doi/10.2777/74150) 26. 26.Kennedy F, Ní Cheallaigh, C., Romero-Ortuno, et al. A study to explore the role of a low threshold, fitness focussed physical rehabilitation intervention with protein supplementation to target physical function and frailty in people with problematic substance use and homelessness: protocol for a single-arm feasibility cohort study. HRB Open Research. 2023;6.doi:10.12688/hrbopenres.13678.1 [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.12688/hrbopenres.13678.1&link_type=DOI) 27. 27.Leong DP, Teo KK, Rangarajan S, Lopez-Jaramillo P, Avezum A, Jr., Orlandini A, et al. Prognostic value of grip strength: findings from the Prospective Urban Rural Epidemiology (PURE) study. Lancet. 2015;386(9990):266-73. doi: 10.1016/S0140-6736(14)62000-6. [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1016/S0140-6736(14)62000-6&link_type=DOI) [PubMed](http://medrxiv.org/lookup/external-ref?access_num=25982160&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2024%2F03%2F02%2F2024.02.29.24303542.atom) 28. 28.Roberts HC, Denison HJ, Martin HJ, Patel HP, Syddall H, Cooper C, et al. A review of the measurement of grip strength in clinical and epidemiological studies: towards a standardised approach. Age Ageing. 2011;40(4):423–9. doi: 10.1093/ageing/afr051. [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1093/ageing/afr051&link_type=DOI) [PubMed](http://medrxiv.org/lookup/external-ref?access_num=21624928&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2024%2F03%2F02%2F2024.02.29.24303542.atom) [Web of Science](http://medrxiv.org/lookup/external-ref?access_num=000291747000006&link_type=ISI) 29. 29.Lein DH, Jr., Alotaibi M, Almutairi M, Singh H. Normative Reference Values and Validity for the 30- Second Chair-Stand Test in Healthy Young Adults. Int J Sports Phys Ther. 2022;17(5):907–14. [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.26603/001c.36432&link_type=DOI) 30. 30.Brooks D, Davis AM, Naglie G. The feasibility of six-minute and two-minute walk tests in in-patient geriatric rehabilitation. Can J Aging. 2007;26(2):159–62. doi: 10.3138/cja.26.2.009. [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.3138/cja.26.2.009&link_type=DOI) [PubMed](http://medrxiv.org/lookup/external-ref?access_num=17613447&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2024%2F03%2F02%2F2024.02.29.24303542.atom) [Web of Science](http://medrxiv.org/lookup/external-ref?access_num=000249191400008&link_type=ISI) 31. 31.Bohannon RW. Comfortable and maximum walking speed of adults aged 20-79 years: reference values and determinants. Age Ageing. 1997;26(1):15–9. doi: 10.1093/ageing/26.1.15. [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1093/ageing/26.1.15&link_type=DOI) [PubMed](http://medrxiv.org/lookup/external-ref?access_num=9143432&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2024%2F03%2F02%2F2024.02.29.24303542.atom) [Web of Science](http://medrxiv.org/lookup/external-ref?access_num=A1997WQ50800003&link_type=ISI) 32. 32.Springer BA, Marin R, Cyhan T, Roberts H, Gill NW. Normative values for the unipedal stance test with eyes open and closed. J Geriatr Phys Ther. 2007;30(1):8–15. doi: 10.1519/00139143-200704000-00003. doi: 10.1519/00139143-200704000-00003. [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1519/00139143-200704000-00003&link_type=DOI) [PubMed](http://medrxiv.org/lookup/external-ref?access_num=19839175&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2024%2F03%2F02%2F2024.02.29.24303542.atom) 33. 33.Romero-Ortuno R, Walsh CD, Lawlor BA & Kenny RA. A frailty instrument for primary care: findings from the Survey of Health, Ageing and Retirement in Europe (SHARE). BMC Geriatr, 2010.10: p. 57. doi: 10.1186/1471-2318-10-57. [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1186/1471-2318-10-57&link_type=DOI) [PubMed](http://medrxiv.org/lookup/external-ref?access_num=20731877&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2024%2F03%2F02%2F2024.02.29.24303542.atom) 34. 34.Hawker GA, Mian S, Kendzerska T, French M. Measures of adult pain: Visual Analog Scale for Pain (VAS Pain), Numeric Rating Scale for Pain (NRS Pain), McGill Pain Questionnaire (MPQ), Short-Form McGill Pain Questionnaire (SF-MPQ), Chronic Pain Grade Scale (CPGS), Short Form-36 Bodily Pain Scale (SF-36 BPS), and Measure of Intermittent and Constant Osteoarthritis Pain (ICOAP). Arthritis Care Res (Hoboken). 2011;63 Suppl 11:S240–52. doi: 10.1002/acr.20543. [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1002/acr.20543&link_type=DOI) [PubMed](http://medrxiv.org/lookup/external-ref?access_num=22588748&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2024%2F03%2F02%2F2024.02.29.24303542.atom) [Web of Science](http://medrxiv.org/lookup/external-ref?access_num=000297219500018&link_type=ISI) 35. 35.Ware J, Jr., Kosinski M, Keller SD. A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care. 1996;34(3):220–33. doi: 10.1097/00005650-199603000-00003. [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1097/00005650-199603000-00003&link_type=DOI) [PubMed](http://medrxiv.org/lookup/external-ref?access_num=8628042&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2024%2F03%2F02%2F2024.02.29.24303542.atom) [Web of Science](http://medrxiv.org/lookup/external-ref?access_num=A1996TZ57700003&link_type=ISI) 36. 36.Guigoz Y, Vellas B, Garry PJ. Assessing the nutritional status of the elderly: The Mini Nutritional Assessment as part of the geriatric evaluation. Nutr Rev. 1996;54(1 Pt 2):S59-65. doi: 10.1111/j.1753-4887.1996.tb03793.x. [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1111/j.1753-4887.1996.tb03793.x&link_type=DOI) [PubMed](http://medrxiv.org/lookup/external-ref?access_num=8919685&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2024%2F03%2F02%2F2024.02.29.24303542.atom) 37. 37.Kaiser MJ, Bauer JM, Ramsch C, Uter W, Guigoz Y, Cederholm T, et al. Validation of the Mini Nutritional Assessment short-form (MNA-SF): a practical tool for identification of nutritional status. J Nutr Health Aging. 2009;13(9):782–8. doi: 10.1007/s12603-009-0214-7. [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1007/s12603-009-0214-7&link_type=DOI) [PubMed](http://medrxiv.org/lookup/external-ref?access_num=19812868&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2024%2F03%2F02%2F2024.02.29.24303542.atom) [Web of Science](http://medrxiv.org/lookup/external-ref?access_num=000271307400005&link_type=ISI) 38. 38.Steiber N. Strong or Weak Handgrip? Normative Reference Values for the German Population across the Life Course Stratified by Sex, Age, and Body Height. PLoS One. 2016;11(10):e0163917. [PubMed](http://medrxiv.org/lookup/external-ref?access_num=http://www.n&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2024%2F03%2F02%2F2024.02.29.24303542.atom) 39. 39.Rolland Y, Lauwers-Cances V, Cournot M, Nourhashémi F, Reynish W, Rivière D, et al. Sarcopenia, calf circumference, and physical function of elderly women: a cross-sectional study. J Am Geriatr Soc. 2003;51(8):1120–4. doi: 10.1046/j.1532-5415.2003.51362.x. [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1046/j.1532-5415.2003.51362.x&link_type=DOI) [PubMed](http://medrxiv.org/lookup/external-ref?access_num=12890076&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2024%2F03%2F02%2F2024.02.29.24303542.atom) [Web of Science](http://medrxiv.org/lookup/external-ref?access_num=000184468400011&link_type=ISI) 40. 40.Gonzalez MC, Mehrnezhad A, Razaviarab N, Barbosa-Silva TG, Heymsfield SB. Calf circumference: cutoff values from the NHANES 1999-2006. Am J Clin Nutr. 2021;113(6):1679–87. doi: 10.1093/ajcn/nqab029. [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1093/ajcn/nqab029&link_type=DOI) [PubMed](http://medrxiv.org/lookup/external-ref?access_num=http://www.n&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2024%2F03%2F02%2F2024.02.29.24303542.atom) 41. 41.Cano NJ, Miolane-Debouit M, Léger J, Heng AE. Assessment of body protein: energy status in chronic kidney disease. Semin Nephrol. 2009;29(1):59–66. doi: 10.1016/j.semnephrol.2008.10.008. [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1016/j.semnephrol.2008.10.008&link_type=DOI) [PubMed](http://medrxiv.org/lookup/external-ref?access_num=19121475&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2024%2F03%2F02%2F2024.02.29.24303542.atom) [Web of Science](http://medrxiv.org/lookup/external-ref?access_num=000262421100008&link_type=ISI) 42. 42.Chen B, Mitchell A, Tran D. "Step up for foot care": addressing podiatric care needs in a sample homeless population. J Am Podiatr Med Assoc. 2014;104(3):269–76. doi: 10.1371/journal.pone.0167463 [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1371/journal.pone.0167463&link_type=DOI) 43. 43.Tang AM, Chung M, Dong KR, Bahwere P, Bose K, Chakraborty R, et al. Determining a global mid- upper arm circumference cut-off to assess underweight in adults (men and non-pregnant women). Public Health Nutr. 2020;23(17):3104–13. doi: 10.1017/S1368980020000397. [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1017/S1368980020000397&link_type=DOI) [PubMed](http://medrxiv.org/lookup/external-ref?access_num=http://www.n&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2024%2F03%2F02%2F2024.02.29.24303542.atom) 44. 44.Borg GA. Psychophysical bases of perceived exertion. Med Sci Sports Exerc. 1982;14(5):377–81. [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1249/00005768-198205000-00012&link_type=DOI) [PubMed](http://medrxiv.org/lookup/external-ref?access_num=7154893&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2024%2F03%2F02%2F2024.02.29.24303542.atom) [Web of Science](http://medrxiv.org/lookup/external-ref?access_num=A1982PP69300010&link_type=ISI) 45. 45.Rosenthal M. Qualitative research methods: Why, when, and how to conduct interviews and focus groups in pharmacy research. Currents in Pharmacy Teaching and Learning. 2016;8(4):509–16. doi:10.1016/j.cptl.2016.03.021. [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1016/j.cptl.2016.03.021&link_type=DOI) 46. 46.Althubaiti A. Sample size determination: A practical guide for health researchers. J Gen Fam Med. 2023;24(2):72–78.doi: 10.1002/jgf2.600. [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1002/JGF2.600&link_type=DOI) 47. 47.Lancaster GA, Dodd S, Williamson PR. Design and analysis of pilot studies: recommendations for good practice. J Eval Clin Practice 2004;10:307–312. doi: 10.1111/j..2002.384.doc.x. [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1111/j..2002.384.doc.x&link_type=DOI) [PubMed](http://medrxiv.org/lookup/external-ref?access_num=15189396&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2024%2F03%2F02%2F2024.02.29.24303542.atom) [Web of Science](http://medrxiv.org/lookup/external-ref?access_num=000221867100019&link_type=ISI) 48. 48.Braun V, Clarke V. What can "thematic analysis" offer health and wellbeing researchers? Int J Qual Stud Health Well-being. 2014;9:26152. doi:10.3402/qhw.v9.26152. [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.3402/qhw.v9.26152&link_type=DOI) [PubMed](http://medrxiv.org/lookup/external-ref?access_num=http://www.n&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2024%2F03%2F02%2F2024.02.29.24303542.atom) 49. 49.Rogans-Watson RS, C. Lewer, D. Armstrong, M and Hudson B. Premature frailty, geriatric conditions and multimorbidity among people experiencing homelessness: a cross-sectional study in a London hostel. Housing Care and Support.2020.23:77-91. DOI: 10.1108/HCS-05-2020-0007. [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1108/HCS-05-2020-0007&link_type=DOI)